Drug recall · March 19, 2025
Livalo (pitavatstatin) tablets recall
Why: Presence of foreign tablets/capsules
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case
- Lots / codes
Lot#: 3231300, Exp 8/2027
- Quantity
- 5,328 Bottles
- Company
- Kowa Pharmaceuticals America, Montgomery, AL
- Distribution
- PA, OH, and TX
- Initiated
- February 24, 2025 · Voluntary: Firm initiated
- Classified
- March 7, 2025
- Reported
- March 19, 2025
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Livalo
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.